LT - MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION
EN - MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07K 16/22 |
|
|
|
A61K 39/395 |
|
European patent
| (11) |
Number of the document |
2510001 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
10794938.0 |
|
Date of filing the European patent application |
2010-12-08 |
| (97) |
Date of publication of the European application |
2012-10-17 |
| (45) |
Date of publication and mention of the grant of the patent |
2015-12-02
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/EP2010/069120 |
|
Date |
2010-12-08 |
PCT application publication
| (87) |
Number |
WO 2011/070045 |
|
Date |
2011-06-16 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
267446 P |
2009-12-08
|
US |
Inventors
| (72) |
MÜLLER, Bernhard, K., DE
|
Grantee
| (73) |
AbbVie Deutschland GmbH & Co KG,
Max-Planck-Ring 2a, 65205 Wiesbaden,
DE
|
Title
| (54) |
MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION |
| |
MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN FOR USE IN THE TREATMENT OF RETINAL NERVE FIBER LAYER DEGENERATION |
